209 related articles for article (PubMed ID: 3163042)
1. Aluminum and phosphate.
Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A
Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042
[No Abstract] [Full Text] [Related]
2. Fewer rejection episodes in kidney graft recipients with aluminum accumulation in bone: an immunosuppressive effect of aluminum toxicity.
Nordal KP; Dahl E; Albrechtsen D; Halse J; Leivestad T; Tretlie S; Fauchald P; Flatmark A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2046-7. PubMed ID: 2652670
[No Abstract] [Full Text] [Related]
3. Aluminum and renal bone disease in Australia.
Dunstan CR; Evans RA
Kidney Int Suppl; 1986 Feb; 18():S65-9. PubMed ID: 3457999
[No Abstract] [Full Text] [Related]
4. Risk factors in aluminum toxicity in children with chronic renal failure.
Santos F; Massie MD; Chan JC
Nephron; 1986; 42(3):189-95. PubMed ID: 3511396
[No Abstract] [Full Text] [Related]
5. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
[No Abstract] [Full Text] [Related]
6. [Dialysis encephalopathy in chronic renal failure].
Markiewicz K; Bubiński R
Pol Tyg Lek; 1980 Jul; 35(30):1159-62. PubMed ID: 7001402
[No Abstract] [Full Text] [Related]
7. Changes in bone histology after treatment with desferrioxamine.
Ott SM; Andress DL; Nebeker HG; Milliner DS; Maloney NA; Coburn JW; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S108-13. PubMed ID: 3457986
[No Abstract] [Full Text] [Related]
8. In vitro and in vivo studies with a non-aluminum phosphate-binding compound.
Schneider HW; Kulbe KD; Weber H; Streicher E
Kidney Int Suppl; 1986 Feb; 18():S120-3. PubMed ID: 3457989
[No Abstract] [Full Text] [Related]
9. Effect of aluminum on bone and cell localization.
Cournot-Witmer G; Plachot JJ; Bourdeau A; Lieberherr M; Jorgetti V; Mendes V; Halpern S; Hemmerle J; Drüeke T; Balsan S
Kidney Int Suppl; 1986 Feb; 18():S37-40. PubMed ID: 3457993
[No Abstract] [Full Text] [Related]
10. Aluminum metabolism and toxicity in renal failure: a review.
Mayor GH; Lohr TO; Sanchez TV
J Environ Pathol Toxicol Oncol; 1985; 6(1):43-50. PubMed ID: 3906081
[No Abstract] [Full Text] [Related]
11. Prevention and treatment of aluminum intoxication in chronic renal failure.
Simon P; Allain P; Ang KS; Cam G; Mauras Y
Adv Nephrol Necker Hosp; 1985; 14():439-78. PubMed ID: 3919543
[No Abstract] [Full Text] [Related]
12. [Current concepts of the role of aluminum in chronic kidney failure patients].
Gruev I; Belovezhdov N
Vutr Boles; 1983; 22(2):1-4. PubMed ID: 6362201
[No Abstract] [Full Text] [Related]
13. Aluminum-induced dialysis osteodystrophy: the demise of "Newcastle bone disease"?
Kerr DN; Ward MK; Arze RS; Ramos JM; Grekas D; Parkinson IS; Ellis HA; Owen JP; Simpson W; Dewar J
Kidney Int Suppl; 1986 Feb; 18():S58-64. PubMed ID: 3457998
[No Abstract] [Full Text] [Related]
14. [Toxic effect of aluminum in chronic renal failure].
Głuszek J
Pol Tyg Lek; 1987 Nov; 42(48):1499-502. PubMed ID: 3451199
[No Abstract] [Full Text] [Related]
15. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.
Smith AJ; Faugère MC; Abreo K; Fanti P; Julian B; Malluche HH
Am J Nephrol; 1986; 6(4):275-83. PubMed ID: 3777036
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
Andress DL; Endres DB; Ott SM; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
[No Abstract] [Full Text] [Related]
17. Role of plasma aluminum in the detection and prevention of aluminum toxicity.
Winney RJ; Cowie JF; Robson JS
Kidney Int Suppl; 1986 Feb; 18():S91-5. PubMed ID: 3458005
[No Abstract] [Full Text] [Related]
18. Aluminum intoxication of bone in renal failure--fact or fiction?
Malluche HH; Faugere MC; Smith AJ; Friedler RM
Kidney Int Suppl; 1986 Feb; 18():S70-3. PubMed ID: 3458000
[No Abstract] [Full Text] [Related]
19. Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.
Sprague SM; Corwin HL; Wilson RS; Mayor GH; Tanner CM
Arch Intern Med; 1986 Oct; 146(10):2063-4. PubMed ID: 3767553
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of various treatment modalities on aluminium associated bone disease.
Ihle BU; Buchanan MR; Stevens B; Becker GJ; Kincaid-Smith P
Proc Eur Dial Transplant Assoc; 1983; 19():195-202. PubMed ID: 6348735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
